Perioperative insulin therapy

[1] Fu Z, Gilbert ER, Liu D. Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes. Curr Diabetes Rev. 2013; 9:25–53.FuZGilbertERLiuDRegulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetesCurr Diabetes Rev2013925–5310.2174/157339913804143225Search in Google Scholar

[2] Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013; 30:803–17.JonesAGHattersleyATThe clinical utility of C-peptide measurement in the care of patients with diabetesDiabet Med201330803–1710.1111/dme.12159Search in Google Scholar

[3] Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005; 26:19–39.WilcoxGInsulin and insulin resistanceClin Biochem Rev20052619–39Search in Google Scholar

[4] Sharp GW. Mechanisms of inhibition of insulin release. Am J Physiol. 1996; 271:C1781–99.SharpGWMechanisms of inhibition of insulin releaseAm J Physiol1996271C1781–9910.1152/ajpcell.1996.271.6.C1781Search in Google Scholar

[5] Korytkowski MT. In-patient management of diabetes: controversies and guidelines. Indian J Endocrinol Metab. 2013; 17:S630–5.KorytkowskiMTIn-patient management of diabetes: controversies and guidelinesIndian J Endocrinol Metab201317S630–510.4103/2230-8210.123554Search in Google Scholar

[6] Redmon B, Caccamo D, Flavin P, Michels R, O’Connor P, Roberts J, et al. Inpatient diabetes management. In: Institute for Clinical Systems Improvement, editors. Diagnosis and management of type 2 diabetes mellitus in adults. 16th ed. [online]. 2014 [cited 2017 Sept 01]; Available from: https://www.ohcoop.org/wp-content/uploads/Clinical-Guidelines-Type-2-Diabetes-in-Adults.pdfRedmonBCaccamoDFlavinPMichelsRO’ConnorPRobertsJet alInpatient diabetes managementInstitute for Clinical Systems Improvement, editors. Diagnosis and management of type 2 diabetes mellitus in adults. 16th ed. [online]. 2014 [cited 2017 Sept 01]Available fromhttps://www.ohcoop.org/wp-content/uploads/Clinical-Guidelines-Type-2-Diabetes-in-Adults.pdfSearch in Google Scholar

[7] Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, et al. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest. 1988; 81:435–41.PolonskyKSGivenBDHirschLShapiroETTillilHBeebeCet alQuantitative study of insulin secretion and clearance in normal and obese subjectsJ Clin Invest198881435–4110.1172/JCI113338Search in Google Scholar

[8] Akhtar S, Barash PG, Inzucchi SE. Scientific principles and clinical implications of perioperative glucose regulation and control. Anesth Analg. 2010; 110:478–97.AkhtarSBarashPGInzucchiSEScientific principles and clinical implications of perioperative glucose regulation and controlAnesth Analg2010110478–9710.1213/ANE.0b013e3181c6be63Search in Google Scholar

[9] Dimitriadis G, Mitrou P, Lambadiari V, Maratou E, Raptis SA. Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract. 2011; 93:S52–9.DimitriadisGMitrouPLambadiariVMaratouERaptisSAInsulin effects in muscle and adipose tissueDiabetes Res Clin Pract201193S52–910.1016/S0168-8227(11)70014-6Search in Google Scholar

[10] Girard M, Schricker T. Perioperative glucose control: living in uncertain times—continuing professional development. Can J Anaesth. 2011; 58:312–20.GirardMSchrickerTPerioperative glucose control: living in uncertain times—continuing professional developmentCan J Anaesth201158312–2010.1007/s12630-010-9449-321258976Search in Google Scholar

[11] Dandona P, Aljada A, Mohanty P, Ghanim H, Bandyopadhyay A, Chaudhuri A. Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care. 2003; 26:3310–4.DandonaPAljadaAMohantyPGhanimHBandyopadhyayAChaudhuriAInsulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9Diabetes Care2003263310–410.2337/diacare.26.12.331014633819Search in Google Scholar

[12] Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005; 111:1448–54.DandonaPAljadaAChaudhuriAMohantyPGargRMetabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammationCirculation20051111448–5410.1161/01.CIR.0000158483.13093.9D15781756Search in Google Scholar

[13] Ng KW, Allen ML, Desai A, Macrae D, Pathan N. Cardioprotective effects of insulin: how intensive insulin therapy may benefit cardiac surgery patients. Circulation. 2012; 125:721–8.NgKWAllenMLDesaiAMacraeDPathanNCardioprotective effects of insulin: how intensive insulin therapy may benefit cardiac surgery patientsCirculation2012125721–810.1161/CIRCULATIONAHA.111.06378422311884Search in Google Scholar

[14] Chaudhuri A, Dandona P, Fonseca V. Cardiovascular benefits of exogenous insulin. J Clin Endocrinol Metab. 2012; 97:3079–91.ChaudhuriADandonaPFonsecaVCardiovascular benefits of exogenous insulinJ Clin Endocrinol Metab2012973079–9110.1210/jc.2012-111222723317Search in Google Scholar

[15] Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S. Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab. 2001; 86:3257–65.DandonaPAljadaAMohantyPGhanimHHamoudaWAssianEAhmadSInsulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab2001863257–6510.1210/jcem.86.7.762311443198Search in Google Scholar

[16] Singh SR, Ahmad F, Lal A, Yu C, Bai Z, Bennett H. Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis. Can Med Assoc J. 2009; 180:385–97.SinghSRAhmadFLalAYuCBaiZBennettHEfficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysisCan Med Assoc J2009180385–9710.1503/cmaj.081041263802519221352Search in Google Scholar

[17] Umpierrez GE, Jones S, Smiley D, Mulligan P, Keyler T, Temponi A, et al. Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes Care. 2009; 32:1164–9.UmpierrezGEJonesSSmileyDMulliganPKeylerTTemponiAet alInsulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trialDiabetes Care2009321164–910.2337/dc09-0169269971119366972Search in Google Scholar

[18] DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA. 2003; 289:2254–64.DeWittDEHirschIBOutpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific reviewJAMA20032892254–6410.1001/jama.289.17.225412734137Search in Google Scholar

[19] Owens DR. Insulin preparations with prolonged effect. Diabetes Technol Ther. 2011; 13:S5–14.OwensDRInsulin preparations with prolonged effectDiabetes Technol Ther201113S5–1410.1089/dia.2011.006821668337Search in Google Scholar

[20] Kalra S, Gupta Y. Clinical use of insulin degludec: practical experience and pragmatic suggestions. N Am J Med Sci. 2015; 7:81–5.KalraSGuptaYClinical use of insulin degludec: practical experience and pragmatic suggestionsN Am J Med Sci2015781–510.4103/1947-2714.153918438277025838998Search in Google Scholar

[21] Donner T. Insulin—pharmacology, therapeutic regimens and principles of intensive insulin therapy. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, et al., editors. Endotext [online]. 2010 [cited 2017 Jan 10]. Available from: https:// www.ncbi.nlm.nih.gov/books/NBK278938/DonnerT. Insulin—pharmacologytherapeutic regimens and principles of intensive insulin therapyDe Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, et al., editors. Endotext [online]2010[cited 2017 Jan 10]. Available fromhttps://www.ncbi.nlm.nih.gov/books/NBK278938/Search in Google Scholar

[22] Heise T, Pieber TR. Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies. Diabetes Obes Metab. 2007; 9:648–59.HeiseTPieberTRTowards peakless, reproducible and long-acting insulinsAn assessment of the basal analogues based on isoglycaemic clamp studies. Diabetes Obes Metab20079648–5910.1111/j.1463-1326.2007.00756.x17645556Search in Google Scholar

[23] Matteucci E, Giampietro O, Covolan V, Giustarini D, Fanti P, Rossi R. Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery. Drug Des Devel Ther. 2015; 9:3109–18.MatteucciEGiampietroOCovolanVGiustariniDFantiPRossiRInsulin administration: present strategies and future directions for a noninvasive (possibly more physiological) deliveryDrug Des Devel Ther201593109–1810.2147/DDDT.S79322447645726124635Search in Google Scholar

[24] Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, Kitabchi AE. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004; 117:291–6.UmpierrezGELatifKStoeverJCuervoRParkLFreireAXKitabchiAEEfficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosisAm J Med2004117291–610.1016/j.amjmed.2004.05.010Search in Google Scholar

[25] Vincent M, Nobecourt E. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies. Diabetes Metab. 2013; 39:299–305.VincentMNobecourtETreatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studiesDiabetes Metab201339299–30510.1016/j.diabet.2012.12.003Search in Google Scholar

[26] Boullu-Sanchis S, Ortega F, Chabrier G, Busch MS, Uhl C, Pinget M, Jeandidier N. Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients. Diabetes Metab. 2006; 32:350–7.Boullu-SanchisSOrtegaFChabrierGBuschMSUhlCPingetMJeandidierNEfficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patientsDiabetes Metab200632350–710.1016/S1262-3636(07)70290-2Search in Google Scholar

[27] Joshi GP, Chung F, Vann MA, Ahmad S, Gan TJ, Goulson DT, et al. Society for ambulatory anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesth Analg. 2010; 111:1378–7.JoshiGPChungFVannMAAhmadSGanTJGoulsonDTet alSociety for ambulatory anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgeryAnesth Analg20101111378–710.1213/ANE.0b013e3181f9c288Search in Google Scholar

[28]The American Diabetes Association. Standards of medical care in diabetes—2017: summary of revisions. Diabetes Care. 2017; 40:S4–5.The American Diabetes AssociationStandards of medical care in diabetes—2017: summary of revisionsDiabetes Care201740S4–510.2337/dc17-S003Search in Google Scholar

[29] Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, et al. American Association of Clinical Endocrinologists and American College of Endocrinology—clinical practice guidelines for developing a diabetes mellitus comprehensive care plan-2015—executive summary. Endocr Pract. 2015; 21:1–87.HandelsmanYBloomgardenZTGrunbergerGUmpierrezGZimmermanRSBaileyTSet alAmerican Association of Clinical Endocrinologists and American College of Endocrinology—clinical practice guidelines for developing a diabetes mellitus comprehensive care plan-2015—executive summaryEndocr Pract2015211–8710.4158/EP15672.GLSUPPLSearch in Google Scholar

[30] Owens DR, Jones MK, Hayes TM, Heding LG, Alberti KG, Home PD, Burrin JM. Comparative study of subcutaneous, intramuscular, and intravenous administration of human insulin. Lancet. 1981; 2:118–22.OwensDRJonesMKHayesTMHedingLGAlbertiKGHomePDBurrinJMComparative study of subcutaneous, intramuscular, and intravenous administration of human insulinLancet19812118–2210.1016/S0140-6736(81)90300-7Search in Google Scholar

[31] Guerra SM, Kitabchi AE. Comparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjects. J Clin Endocrinol Metab. 1976; 42:869–74.GuerraSMKitabchiAEComparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjectsJ Clin Endocrinol Metab197642869–7410.1210/jcem-42-5-8691270578Search in Google Scholar

[32] Evans CH, Lee J, Ruhlman MK. Optimal glucose management in the perioperative period. Surg Clin North Am. 2015; 95:337–54.EvansCHLeeJRuhlmanMKOptimal glucose management in the perioperative periodSurg Clin North Am201595337–5410.1016/j.suc.2014.11.00325814110Search in Google Scholar

[33] Sato H, Carvalho G, Sato T, Lattermann R, Matsukawa T, Schricker T. The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab. 2010; 95:4338–44.SatoHCarvalhoGSatoTLattermannRMatsukawaTSchrickerTThe association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgeryJ Clin Endocrinol Metab2010954338–4410.1210/jc.2010-013520631016Search in Google Scholar

[34] Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2012; 97:16–38.UmpierrezGEHellmanRKorytkowskiMTKosiborodMMaynardGAMontoriVMet alManagement of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society Clinical Practice GuidelineJ Clin Endocrinol Metab20129716–3810.1210/jc.2011-209822223765Search in Google Scholar

[35] Gosmanov AR, Umpierrez GE. Management of hyperglycemia during enteral and parenteral nutrition therapy. Curr Diab Rep. 2013; 13:155–62.GosmanovARUmpierrezGEManagement of hyperglycemia during enteral and parenteral nutrition therapyCurr Diab Rep201313155–6210.1007/s11892-012-0335-y374649123065369Search in Google Scholar

[36] Carvalho G, Lattermann R, Codere-Maruyama T, Schricker T. Glucose and insulin administration while maintaining normoglycemia: the GIN concept. Minerva Anestesiol. 2013; 79:74–82.CarvalhoGLattermannRCodere-MaruyamaTSchrickerTGlucose and insulin administration while maintaining normoglycemia: the GIN conceptMinerva Anestesiol20137974–82Search in Google Scholar

[37] Dagogo-Jack S, Alberti KGMM. Management of diabetes mellitus in surgical patients. Diabetes Spectr. 2002; 15:44–8.Dagogo-JackSAlbertiKGMMManagement of diabetes mellitus in surgical patientsDiabetes Spectr20021544–810.2337/diaspect.15.1.44Search in Google Scholar

[38] Association of Anaesthetists of Great Britain and Ireland, Working party members:, Barker P, Creasey PE, Dhatariya K, Levy N, et al. Peri-operative management of the surgical patient with diabetes 2015. Anaesthesia. 2015; 70:1427–40.Association of Anaesthetists of Great Britain and Ireland, Working party membersBarkerPCreaseyPEDhatariyaKLevyNet alPeri-operative management of the surgical patient with diabetes 2015Anaesthesia2015701427–4010.1111/anae.13233505491726417892Search in Google Scholar

[39] Patient Safety Alert. ‘High-alert’ medications and patient safety. Int J Qual Health Care. 2001; 13:339–40.Patient Safety Alert‘High-alert’ medications and patient safetyInt J Qual Health Care200113339–4010.1093/intqhc/13.4.33911560354Search in Google Scholar

[40] Koczmara C, Jelincic V, Dueck C. Dangerous abbreviations: “U” can make a difference. Dynamics. 2005; 16:11–5.KoczmaraCJelincicVDueckCDangerous abbreviations: “U” can make a differenceDynamics20051611–5Search in Google Scholar

[41] Koczmara C, Hyland S, Jelincic V. High alert: preventing insulin errors. Dynamics. 2004; 15:10–1.KoczmaraCHylandSJelincicVHigh alert: preventing insulin errorsDynamics20041510–1Search in Google Scholar

[42] Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J, et al. Glucose metabolism and catecholamines. Crit Care Med. 2007; 35:S508–18.BarthEAlbusziesGBaumgartKMatejovicMWachterUVogtJet alGlucose metabolism and catecholaminesCrit Care Med200735S508–1810.1097/01.CCM.0000278047.06965.2017713401Search in Google Scholar

[43] Vanhorebeek I, Van den Berghe G. Diabetes of injury: novel insights. Endocrinol Metab Clin North Am. 2006; 35:859–72.VanhorebeekIVanden Berghe GDiabetes of injury: novel insightsEndocrinol Metab Clin North Am200635859–7210.1016/j.ecl.2006.09.00217127151Search in Google Scholar

[44] Thorell A, Efendic S, Gutniak M, Haggmark T, Ljungqvist O. Development of postoperative insulin resistance is associated with the magnitude of operation. Eur J Surg. 1993; 159:593–9.ThorellAEfendicSGutniakMHaggmarkTLjungqvistODevelopment of postoperative insulin resistance is associated with the magnitude of operationEur J Surg1993159593–9Search in Google Scholar

[45] Thorell A, Efendic S, Gutniak M, Haggmark T, Ljungqvist O. Insulin resistance after abdominal surgery. Br J Surg. 1994; 81:59–63.ThorellAEfendicSGutniakMHaggmarkTLjungqvistOInsulin resistance after abdominal surgeryBr J Surg19948159–6310.1002/bjs.18008101208313123Search in Google Scholar

[46] Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E, et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemiaindependent actions of insulin. Diabetes. 2006; 55:1096–105.EllgerBDebaveyeYVanhorebeekILangoucheLGiuliettiAVanEtten Eet alSurvival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemiaindependent actions of insulinDiabetes2006551096–10510.2337/diabetes.55.04.06.db05-143416567534Search in Google Scholar

[47] Sato H, Hatzakorzian R, Carvalho G, Sato T, Lattermann R, Matsukawa T, Schricker T. High-dose insulin administration improves left ventricular function after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2011; 25:1086–91.SatoHHatzakorzianRCarvalhoGSatoTLattermannRMatsukawaTSchrickerTHigh-dose insulin administration improves left ventricular function after coronary artery bypass graft surgeryJ Cardiothorac Vasc Anesth2011251086–9110.1053/j.jvca.2011.05.00921757376Search in Google Scholar

[48] Albacker TB, Carvalho G, Schricker T, Lachapelle K. Myocardial protection during elective coronary artery bypass grafting using high-dose insulin therapy. Ann Thorac Surg. 2007; 84:1920–7.AlbackerTBCarvalhoGSchrickerTLachapelleKMyocardial protection during elective coronary artery bypass grafting using high-dose insulin therapyAnn Thorac Surg2007841920–710.1016/j.athoracsur.2007.07.001Search in Google Scholar

[49] Shim JK, Yang SY, Yoo YC, Yoo KJ, Kwak YL. Myocardial protection by glucose-insulin-potassium in acute coronary syndrome patients undergoing urgent multivessel off-pump coronary artery bypass surgery. Br J Anaesth. 2013; 110:47–53.ShimJKYangSYYooYCYooKJKwakYLMyocardial protection by glucose-insulin-potassium in acute coronary syndrome patients undergoing urgent multivessel off-pump coronary artery bypass surgeryBr J Anaesth201311047–5310.1093/bja/aes324Search in Google Scholar

[50] Howell NJ, Ashrafian H, Drury NE, Ranasinghe AM, Contractor H, Isackson H, et al. Glucose-insulin-potassium reduces the incidence of low cardiac output episodes after aortic valve replacement for aortic stenosis in patients with left ventricular hypertrophy: results from the hypertrophy, insulin, glucose, and electrolytes (HINGE) trial. Circulation. 2011; 123:170–7.HowellNJAshrafianHDruryNERanasingheAMContractorHIsacksonHet alGlucose-insulin-potassium reduces the incidence of low cardiac output episodes after aortic valve replacement for aortic stenosis in patients with left ventricular hypertrophy: results from the hypertrophy, insulin, glucose, and electrolytes (HINGE) trialCirculation2011123170–710.1161/CIRCULATIONAHA.110.945170Search in Google Scholar

[51] Demircan S, Yazici M, Diraman E, Demircan G, Kilicaslan F, Durna K, et al. The effect of glucose-insulin-potassium treatment on myocardial oxidative stress in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Coron Artery Dis. 2008; 19:99–104.DemircanSYaziciMDiramanEDemircanGKilicaslanFDurnaKet alThe effect of glucose-insulin-potassium treatment on myocardial oxidative stress in patients with acute coronary syndromes undergoing percutaneous coronary interventionCoron Artery Dis20081999–10410.1097/MCA.0b013e3282f27c34Search in Google Scholar

[52] Gosmanov AR, Gosmanova EO, Dillard-Cannon E. Management of adult diabetic ketoacidosis. Diabetes Metab Syndr Obes. 2014; 7:255–64.GosmanovARGosmanovaEODillard-CannonEManagement of adult diabetic ketoacidosisDiabetes Metab Syndr Obes20147255–6410.2147/DMSO.S50516Search in Google Scholar

[53] Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes. 1988; 37:901–7.AmielSASherwinRSSimonsonDCTamborlaneWVEffect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone releaseDiabetes198837901–710.2337/diab.37.7.901Search in Google Scholar

[54] Liamis G, Liberopoulos E, Barkas F, Elisaf M. Diabetes mellitus and electrolyte disorders. World J Clin Cases. 2014; 2:488–96.LiamisGLiberopoulosEBarkasFElisafMDiabetes mellitus and electrolyte disordersWorld J Clin Cases20142488–9610.12998/wjcc.v2.i10.488Search in Google Scholar

[55] Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009; 373:1798–807.DunganKMBraithwaiteSSPreiserJCStress hyperglycaemiaLancet20093731798–80710.1016/S0140-6736(09)60553-5Search in Google Scholar

[56] De Vries FEE, Gans SL, Solomkin JS, Allegranzi B, Egger M, Dellinger EP, Boermeester MA. Meta-analysis of lower perioperative blood glucose target levels for reduction of surgical-site infection. Br J Surg. 2017; 104:e95–105.DeVries FEEGansSLSolomkinJSAllegranziBEggerMDellingerEPBoermeesterMAMeta-analysis of lower perioperative blood glucose target levels for reduction of surgical-site infectionBr J Surg2017104e95–10510.1002/bjs.1042427901264Search in Google Scholar

[57] Frisch A, Chandra P, Smiley D, Peng L, Rizzo M, Gatcliffe C, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010; 33:1783–8.FrischAChandraPSmileyDPengLRizzoMGatcliffeCet alPrevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgeryDiabetes Care2010331783–810.2337/dc10-0304290906220435798Search in Google Scholar

[58] Kwon S, Thompson R, Dellinger P, Yanez D, Farrohki E, Flum D. Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg. 2013; 257:8–14.KwonSThompsonRDellingerPYanezDFarrohkiEFlumDImportance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment programAnn Surg20132578–1410.1097/SLA.0b013e31827b6bbc420843323235393Search in Google Scholar

[59] Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359–67.Vanden Berghe GWoutersPWeekersFVerwaestCBruyninckxFSchetzMet alIntensive insulin therapy in critically ill patientsN Engl J Med20013451359–6710.1056/NEJMoa01130011794168Search in Google Scholar

[60] D’Alessandro C, Leprince P, Golmard JL, Ouattara A, Aubert S, Pavie A, et al. Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg. 2007; 134:29–37.D’AlessandroCLeprincePGolmardJLOuattaraAAubertSPavieAet alStrict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularizationJ Thorac Cardiovasc Surg200713429–3710.1016/j.jtcvs.2007.02.02817599483Search in Google Scholar

[61] Kirdemir P, Yildirim V, Kiris I, Gulmen S, Kuralay E, Ibrisim E, Ozal E. Does continuous insulin therapy reduce postoperative supraventricular tachycardia incidence after coronary artery bypass operations in diabetic patients? J Cardiothorac Vasc Anesth. 2008; 22:383–7.KirdemirPYildirimVKirisIGulmenSKuralayEIbrisimEOzalEDoes continuous insulin therapy reduce postoperative supraventricular tachycardia incidence after coronary artery bypass operations in diabetic patients? J Cardiothorac Vasc Anesth200822383–710.1053/j.jvca.2007.09.01518503925Search in Google Scholar

[62] Kotagal M, Symons RG, Hirsch IB, Umpierrez GE, Dellinger EP, Farrokhi ET, et al. Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg. 2015; 261:97–103.KotagalMSymonsRGHirschIBUmpierrezGEDellingerEPFarrokhiETet alPerioperative hyperglycemia and risk of adverse events among patients with and without diabetesAnn Surg201526197–10310.1097/SLA.0000000000000688420893925133932Search in Google Scholar

[63] Buehler L, Fayfman M, Alexopoulos AS, Zhao L, Farrokhi F, Weaver J, et al. The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients. J Diabetes Complications. 2015; 29:1177–82.BuehlerLFayfmanMAlexopoulosASZhaoLFarrokhiFWeaverJet alThe impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patientsJ Diabetes Complications2015291177–8210.1016/j.jdiacomp.2015.07.02726355027Search in Google Scholar

[64] Margonis GA, Amini N, Sasaki K, Kim Y, Merath K, Buettner S, et al. Perioperative hyperglycemia and postoperative outcomes in patients undergoing resection of colorectal liver metastases. J Gastrointest Surg. 2017; 21:228–37.MargonisGAAminiNSasakiKKimYMerathKBuettnerSet alPerioperative hyperglycemia and postoperative outcomes in patients undergoing resection of colorectal liver metastasesJ Gastrointest Surg201721228–3710.1007/s11605-016-3278-927678503Search in Google Scholar

[65] Kremers HM, Schleck CD, Lewallen EA, Larson DR, Van Wijnen AJ, Lewallen DG. Diabetes mellitus and hyperglycemia and the risk of aseptic loosening in total joint arthroplasty. J Arthroplasty. 2017; 32:s251–3.KremersHMSchleckCDLewallenEALarsonDRVanWijnen AJLewallenDGDiabetes mellitus and hyperglycemia and the risk of aseptic loosening in total joint arthroplastyJ Arthroplasty201732s251–310.1016/j.arth.2017.02.05628343827Search in Google Scholar

[66] Fisette A, Hassanain M, Metrakos P, Doi SA, Salman A, Schricker T, et al. High-dose insulin therapy reduces postoperative liver dysfunction and complications in liver resection patients through reduced apoptosis and altered inflammation. J Clin Endocrinol Metab. 2012; 97:217–26.FisetteAHassanainMMetrakosPDoiSASalmanASchrickerTet alHigh-dose insulin therapy reduces postoperative liver dysfunction and complications in liver resection patients through reduced apoptosis and altered inflammationJ Clin Endocrinol Metab201297217–2610.1210/jc.2011-159822031518Search in Google Scholar

[67] Hassanain M, Metrakos P, Fisette A, Doi SA, Schricker T, Lattermann R, et al. Randomized clinical trial of the impact of insulin therapy on liver function in patients undergoing major liver resection. Br J Surg. 2013; 100:610–8.HassanainMMetrakosPFisetteADoiSASchrickerTLattermannRet alRandomized clinical trial of the impact of insulin therapy on liver function in patients undergoing major liver resectionBr J Surg2013100610–810.1002/bjs.903423339047Search in Google Scholar

[68] Duncan AE, Abd-Elsayed A, Maheshwari A, Xu M, Soltesz E, Koch CG. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology. 2010; 112:860–71.DuncanAEAbd-ElsayedAMaheshwariAXuMSolteszEKochCGRole of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgeryAnesthesiology2010112860–7110.1097/ALN.0b013e3181d3d4b420216389Search in Google Scholar

[69] Yoo S, Lee HJ, Lee H, Ryu HG. Association between perioperative hyperglycemia or glucose variability and postoperative acute kidney injury after liver transplantation: a retrospective observational study. Anesth Analg. 2017; 124:35–41.YooSLeeHJLeeHRyuHGAssociation between perioperative hyperglycemia or glucose variability and postoperative acute kidney injury after liver transplantation: a retrospective observational studyAnesth Analg201712435–4110.1213/ANE.000000000000163227749341Search in Google Scholar

[70] Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008; 36:3008–13.KrinsleyJSGlycemic variability: a strong independent predictor of mortality in critically ill patientsCrit Care Med2008363008–1310.1097/CCM.0b013e31818b38d218824908Search in Google Scholar

[71] Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006; 105:244–52.EgiMBellomoRStachowskiEFrenchCJHartGVariability of blood glucose concentration and short-term mortality in critically ill patientsAnesthesiology2006105244–5210.1097/00000542-200608000-0000616871057Search in Google Scholar

[72] Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006; 295:1681–7.MonnierLMasEGinetCMichelFVillonLCristolJPColetteCActivation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetesJAMA20062951681–710.1001/jama.295.14.168116609090Search in Google Scholar

[73] Houlden R, Capes S, Clement M, Miller D. In-hospital management of diabetes. Can J Diabetes. 2013; 37:S77–81.HouldenRCapesSClementMMillerDIn-hospital management of diabetesCan J Diabetes201337S77–8110.1016/j.jcjd.2013.01.02424070968Search in Google Scholar

[74] Dhatariya K, Levy N, Kilvert A, Watson B, Cousins D, Flanagan D, et al. NHS diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. 2012; 29:420–33.DhatariyaKLevyNKilvertAWatsonBCousinsDFlanaganDet alNHS diabetes guideline for the perioperative management of the adult patient with diabetesDiabet Med201229420–3310.1111/j.1464-5491.2012.03582.x22288687Search in Google Scholar

[75] Abdelmalak BB, Knittel J, Abdelmalak JB, Dalton JE, Christiansen E, Foss J, et al. Preoperative blood glucose concentrations and postoperative outcomes after elective non-cardiac surgery: an observational study. Br J Anaesth. 2014; 112:79–88.AbdelmalakBBKnittelJAbdelmalakJBDaltonJEChristiansenEFossJet alPreoperative blood glucose concentrations and postoperative outcomes after elective non-cardiac surgery: an observational studyBr J Anaesth201411279–8810.1097/SA.0000000000000076Search in Google Scholar

[76] Noordzij PG, Boersma E, Schreiner F, Kertai MD, Feringa HH, Dunkelgrun M, et al. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol. 2007; 156:137–42.NoordzijPGBoersmaESchreinerFKertaiMDFeringaHHDunkelgrunMet alIncreased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgeryEur J Endocrinol2007156137–4210.1530/eje.1.0232117218737Search in Google Scholar

[77] Abdelmalak B, Abdelmalak JB, Knittel J, Christiansen E, Mascha E, Zimmerman R, et al. The prevalence of undiagnosed diabetes in non-cardiac surgery patients, an observational study. Can J Anaesth. 2010; 57:1058–64.AbdelmalakBAbdelmalakJBKnittelJChristiansenEMaschaEZimmermanRet alThe prevalence of undiagnosed diabetes in non-cardiac surgery patients, an observational studyCan J Anaesth2010571058–6410.1007/s12630-010-9391-420922587Search in Google Scholar

[78] Hatzakorzian R, Bui H, Carvalho G, Shan WL, Sidhu S, Schricker T. Fasting blood glucose levels in patients presenting for elective surgery. Nutrition. 2011; 27:298–301.HatzakorzianRBuiHCarvalhoGShanWLSidhuSSchrickerTFasting blood glucose levels in patients presenting for elective surgeryNutrition201127298–30110.1016/j.nut.2010.02.00320541364Search in Google Scholar

[79] Krinsley JS. Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital. Semin Thorac Cardiovasc Surg. 2006; 18:317–25.KrinsleyJSGlycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospitalSemin Thorac Cardiovasc Surg200618317–2510.1053/j.semtcvs.2006.12.00317395028Search in Google Scholar

[80] Lauruschkat AH, Arnrich B, Albert AA, Walter JA, Amann B, Rosendahl UP, et al. Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting. Circulation. 2005; 112:2397–402.LauruschkatAHArnrichBAlbertAAWalterJAAmannBRosendahlUPet alPrevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass graftingCirculation20051122397–40210.1161/CIRCULATIONAHA.105.53454516230496Search in Google Scholar

[81] Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin A_Ic in diabetes mellitus. N Engl J Med. 1976; 295:417–20.KoenigRJPetersonCMJonesRLSaudekCLehrmanMCeramiACorrelation of glucose regulation and hemoglobin A_Ic in diabetes mellitusN Engl J Med1976295417–2010.1056/NEJM197608192950804934240Search in Google Scholar

[82] Gustafsson UO, Thorell A, Soop M, Ljungqvist O, Nygren J. Haemoglobin A1c as a predictor of postoperative hyperglycaemia and complications after major colorectal surgery. Br J Surg. 2009; 96:1358–64.GustafssonUOThorellASoopMLjungqvistONygrenJHaemoglobin A1c as a predictor of postoperative hyperglycaemia and complications after major colorectal surgeryBr J Surg2009961358–6410.1002/bjs.672419847870Search in Google Scholar

[83] Goh SNS, Yeoh E, Tan KY. Impact of perioperative hypoglycemia in subjects with diabetes undergoing colorectal surgery. Int J Colorectal Dis. 2017; 32:209–14.GohSNSYeohETanKYImpact of perioperative hypoglycemia in subjects with diabetes undergoing colorectal surgeryInt J Colorectal Dis201732209–1410.1007/s00384-016-2680-927864588Search in Google Scholar

[84] Halkos ME, Puskas JD, Lattouf OM, Kilgo P, Kerendi F, Song HK, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2008; 136:631–40.HalkosMEPuskasJDLattoufOMKilgoPKerendiFSongHKet alElevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgeryJ Thorac Cardiovasc Surg2008136631–4010.1016/j.jtcvs.2008.02.09118805264Search in Google Scholar

[85] O’Sullivan CJ, Hynes N, Mahendran B, Andrews EJ, Avalos G, Tawfik S, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg. 2006; 32:188–97.O’SullivanCJHynesNMahendranBAndrewsEJAvalosGTawfikSet alHaemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patientsIs HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg200632188–97Search in Google Scholar

[86] Ljungqvist O, Nygren J, Thorell A. Insulin resistance and elective surgery. Surgery. 2000; 128:757–60.LjungqvistONygrenJThorellAInsulin resistance and elective surgerySurgery2000128757–6010.1067/msy.2000.10716611056438Search in Google Scholar

[87] Thorell A, Nygren J, Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care. 1999; 2:69–78.ThorellANygrenJLjungqvistOInsulin resistance: a marker of surgical stressCurr Opin Clin Nutr Metab Care1999269–7810.1097/00075197-199901000-0001210453333Search in Google Scholar

[88] National Guideline Centre (UK). Preoperative tests (update): routine preoperative tests for elective surgery. London: National Institute for Health and Care Excellence (UK); 2016.National Guideline Centre (UK)Preoperative tests (update): routine preoperative tests for elective surgeryLondonNational Institute for Health and Care Excellence (UK)2016Search in Google Scholar

[89] Bock M, Johansson T, Fritsch G, Flamm M, Hansbauer B, Mann E, Sönnichsen A. The impact of preoperative testing for blood glucose concentration and haemoglobin A1c on mortality, changes in management and complications in noncardiac elective surgery: a systematic review. Eur J Anaesthesiol. 2015; 32:152–9.BockMJohanssonTFritschGFlammMHansbauerBMannESönnichsenAThe impact of preoperative testing for blood glucose concentration and haemoglobin A1c on mortality, changes in management and complications in noncardiac elective surgery: a systematic reviewEur J Anaesthesiol201532152–910.1097/EJA.000000000000011725046561Search in Google Scholar

[90] Partridge H, Perkins B, Mathieu S, Nicholls A, Adeniji K. Clinical recommendations in the management of the patient with type 1 diabetes on insulin pump therapy in the perioperative period: a primer for the anaesthetist. Br J Anaesth. 2016; 116:18–26.PartridgeHPerkinsBMathieuSNichollsAAdenijiKClinical recommendations in the management of the patient with type 1 diabetes on insulin pump therapy in the perioperative period: a primer for the anaesthetistBr J Anaesth201611618–2610.1093/bja/aev34726675948Search in Google Scholar

[91] Sudhakaran S, Surani SR. Guidelines for perioperative management of the diabetic patient. Surg Res Pract. 2015; 2015:284063. 10.1155/2015/284063.SudhakaranSSuraniSRGuidelines for perioperative management of the diabetic patientSurg Res Pract2015201528406310.1155/2015/284063445249926078998Open DOISearch in Google Scholar

[92] Marks JB. Perioperative management of diabetes. Am Fam Physician. 2003; 67:93–100.MarksJBPerioperative management of diabetesAm Fam Physician20036793–100Search in Google Scholar

[93] Schricker T, Lattermann R. Perioperative catabolism. Can J Anaesth. 2015; 62:182–93.SchrickerTLattermannRPerioperative catabolismCan J Anaesth201562182–9310.1007/s12630-014-0274-y25588775Search in Google Scholar

[94] Sato H, Lattermann R, Carvalho G, Sato T, Metrakos P, Hassanain M, et al. Perioperative glucose and insulin administration while maintaining normoglycemia (GIN therapy) in patients undergoing major liver resection. Anesth Analg. 2010; 110:1711–8.SatoHLattermannRCarvalhoGSatoTMetrakosPHassanainMet alPerioperative glucose and insulin administration while maintaining normoglycemia (GIN therapy) in patients undergoing major liver resectionAnesth Analg20101101711–810.1213/ANE.0b013e3181d9008720375299Search in Google Scholar

[95]Carvalho G, Moore A, Qizilbash B, Lachapelle K, Schricker T. Maintenance of normoglycemia during cardiac surgery. Anesth Analg. 2004; 99:319–24.CarvalhoGMooreAQizilbashBLachapelleKSchrickerTMaintenance of normoglycemia during cardiac surgeryAnesth Analg200499319–2410.1213/01.ANE.0000121769.62638.EB15271698Search in Google Scholar

[96] Carvalho G, Pelletier P, Albacker T, Lachapelle K, Joanisse DR, Hatzakorzian R, et al. Cardioprotective effects of glucose and insulin administration while maintaining normoglycemia (GIN therapy) in patients undergoing coronary artery bypass grafting. J Clin Endocrinol Metab. 2011; 96:1469–77.CarvalhoGPelletierPAlbackerTLachapelleKJoanisseDRHatzakorzianRet alCardioprotective effects of glucose and insulin administration while maintaining normoglycemia (GIN therapy) in patients undergoing coronary artery bypass graftingJ Clin Endocrinol Metab2011961469–7710.1210/jc.2010-193421346060Search in Google Scholar

[97] Albacker T, Carvalho G, Schricker T, Lachapelle K. High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. Ann Thorac Surg. 2008; 86:20–7.AlbackerTCarvalhoGSchrickerTLachapelleKHigh-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patientsAnn Thorac Surg20088620–710.1016/j.athoracsur.2008.03.04618573392Search in Google Scholar

[98] Karon BS, Donato LJ, Larsen CM, Siebenaler LK, Wells AE, Wood-Wentz CM, et al. Accuracy of capillary and arterial whole blood glucose measurements using a glucose meter in patients under general anesthesia in the operating room. Anesthesiology. 2017; 127:466–74.KaronBSDonatoLJLarsenCMSiebenalerLKWellsAEWood-WentzCMet alAccuracy of capillary and arterial whole blood glucose measurements using a glucose meter in patients under general anesthesia in the operating roomAnesthesiology2017127466–7410.1097/ALN.0000000000001708556147528557817Search in Google Scholar

[99] Karon BS, Meeusen JW, Bryant SC. Impact of glucose meter error on glycemic variability and time in target range during glycemic control after cardiovascular surgery. J Diabetes Sci Technol. 2016; 10:336–42.KaronBSMeeusenJWBryantSCImpact of glucose meter error on glycemic variability and time in target range during glycemic control after cardiovascular surgeryJ Diabetes Sci Technol201610336–4210.1177/1932296815602099477395326311721Search in Google Scholar

[100] Egi M, Bellomo R. Reducing glycemic variability in intensive care unit patients: a new therapeutic target? J Diabetes Sci Technol. 2009; 3:1302–8.EgiMBellomoRReducing glycemic variability in intensive care unit patients: a new therapeutic target? J Diabetes Sci Technol200931302–810.1177/193229680900300610278703020144384Search in Google Scholar

[101] Sato H, Hosojima M, Ishikawa T, Aoki K, Okamoto T, Saito A, Tsuchida M. Glucose variability based in continuous glucose monitoring assessment is associated with postoperative complications after cardiovascular surgery. Ann Thorac Cardiovasc Surg. 2017; 23:239–47.SatoHHosojimaMIshikawaTAokiKOkamotoTSaitoATsuchidaMGlucose variability based in continuous glucose monitoring assessment is associated with postoperative complications after cardiovascular surgeryAnn Thorac Cardiovasc Surg201723239–4710.5761/atcs.oa.17-00045565533628717057Search in Google Scholar

[102] Gomez AM, Umpierrez GE. Continuous glucose monitoring in insulin-treated patients in non-ICU settings. J Diabetes Sci Technol. 2014; 8:930–6.GomezAMUmpierrezGEContinuous glucose monitoring in insulin-treated patients in non-ICU settingsJ Diabetes Sci Technol20148930–610.1177/1932296814546025445538425125454Search in Google Scholar

[103] Donatelli F, Vavassori A, Bonfanti S, Parrella P, Lorini L, Fumagalli R, Carli F. Epidural anesthesia and analgesia decrease the postoperative incidence of insulin resistance in preoperative insulin-resistant subjects only. Anesth Analg. 2007; 104:1587–93.DonatelliFVavassoriABonfantiSParrellaPLoriniLFumagalliRCarliFEpidural anesthesia and analgesia decrease the postoperative incidence of insulin resistance in preoperative insulin-resistant subjects onlyAnesth Analg20071041587–9310.1213/01.ane.0000261506.48816.5c17513663Search in Google Scholar

[104] Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007; 30:2181–6.UmpierrezGESmileyDZismanAPrietoLMPalacioACeronMet alRandomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial)Diabetes Care2007302181–610.2337/dc07-029517513708Search in Google Scholar